DENISCHEMPharmaceuticals
Denis Chem Lab Ltd — Profit & Loss Statement
₹56.54
-4.91%
Denis Chem Lab Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | -0.65 Cr | — |
| Tax Rate For Calcs | 0.27 | 0.26 | 0.28 | 0.29 | — |
| Normalized EBITDA | 18.48 Cr | 22.62 Cr | 19.37 Cr | 17.34 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | -2.20 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | -2.20 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Reconciled Depreciation | 6.86 Cr | 6.95 Cr | 7.82 Cr | 5.76 Cr | — |
| Reconciled Cost Of Revenue | 95.77 Cr | 86.90 Cr | 84.46 Cr | 74.22 Cr | — |
| EBITDA | 18.48 Cr | 22.62 Cr | 19.37 Cr | 15.14 Cr | — |
| EBIT | 11.62 Cr | 15.68 Cr | 11.56 Cr | 9.38 Cr | — |
| Net Interest Income | -0.51 Cr | -0.54 Cr | -0.64 Cr | -0.56 Cr | — |
| Interest Expense | 0.51 Cr | 0.54 Cr | 0.64 Cr | 0.50 Cr | — |
| Normalized Income | 8.08 Cr | 11.16 Cr | 7.86 Cr | 7.82 Cr | — |
| Net Income From Continuing And Discontinued Operation | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Total Expenses | 164.05 Cr | 153.53 Cr | 149.88 Cr | 124.83 Cr | — |
| Diluted NI Availto Com Stockholders | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Net Income Common Stockholders | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Net Income Including Noncontrolling Interests | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 8.08 Cr | 11.16 Cr | 7.86 Cr | 6.26 Cr | — |
| Tax Provision | 3.04 Cr | 3.98 Cr | 3.06 Cr | 2.62 Cr | — |
| Pretax Income | 11.11 Cr | 15.13 Cr | 10.92 Cr | 8.88 Cr | — |
| Other Non Operating Income Expenses | 2.37 Cr | 1.39 Cr | 0.59 Cr | 1.05 Cr | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | -2.20 Cr | — |
| Net Non Operating Interest Income Expense | -0.51 Cr | -0.54 Cr | -0.64 Cr | -0.56 Cr | — |
| Interest Expense Non Operating | 0.51 Cr | 0.54 Cr | 0.64 Cr | 0.50 Cr | — |
| Operating Income | 9.25 Cr | 14.29 Cr | 10.96 Cr | 11.66 Cr | — |
| Operating Expense | 68.29 Cr | 66.63 Cr | 65.42 Cr | 50.60 Cr | — |
| Other Operating Expenses | 46.16 Cr | 45.30 Cr | 44.58 Cr | 19.04 Cr | — |
| Depreciation And Amortization In Income Statement | 6.86 Cr | 6.95 Cr | 7.82 Cr | 5.76 Cr | — |
| Depreciation Income Statement | 6.86 Cr | 6.95 Cr | 7.82 Cr | 5.76 Cr | — |
| Gross Profit | 77.53 Cr | 80.92 Cr | 76.39 Cr | 62.27 Cr | — |
| Cost Of Revenue | 95.77 Cr | 86.90 Cr | 84.46 Cr | 74.22 Cr | — |
| Total Revenue | 173.30 Cr | 167.82 Cr | 160.85 Cr | 136.49 Cr | — |
| Operating Revenue | 173.30 Cr | 167.82 Cr | 160.85 Cr | 136.49 Cr | — |
| Diluted Average Shares | — | 1.39 Cr | 1.39 Cr | 1.39 Cr | 1.39 Cr |
| Basic Average Shares | — | 1.39 Cr | 1.39 Cr | 1.39 Cr | 1.39 Cr |
| Diluted EPS | — | 8.04 | 5.66 | 4.51 | 1.63 |
| Basic EPS | — | 8.04 | 5.66 | 4.51 | 1.63 |
| Interest Income | — | — | 0.47 Cr | 0.19 Cr | 0.18 Cr |
| Rent Expense Supplemental | — | — | 0.30 Cr | 0.21 Cr | 0.08 Cr |
| Write Off | — | — | 2.06 Cr | 2.23 Cr | 2.99 Cr |
| Total Other Finance Cost | — | — | 0.34 Cr | 0.26 Cr | 0.35 Cr |
| Interest Income Non Operating | — | — | 0.47 Cr | 0.19 Cr | 0.18 Cr |
| Selling General And Administration | — | — | 15.23 Cr | 13.92 Cr | 12.16 Cr |
| Selling And Marketing Expense | — | — | 13.87 Cr | 12.80 Cr | 10.86 Cr |
| General And Administrative Expense | — | — | 1.36 Cr | 1.13 Cr | 1.30 Cr |
| Rent And Landing Fees | — | — | 0.30 Cr | 0.21 Cr | 0.08 Cr |
| Other Special Charges | — | — | — | -0.03 Cr | 0.17 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Denis Chem Lab Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.